Logos (3)

Partner Resource Hub: Enabling Joint Account Succcess

Use this resource hub to introduce CancerIQ to your accounts, demonstrate how it complements Myriad testing, and open new doors for program growth. Inside you’ll find quick explainers, sales tools, case studies, and best practices to help your sites launch or expand precision prevention programs with confidence.

ORDERING GUIDES

How To Order Myriad Tests within CancerIQ

Ordering Myriad Precise Oncology Somatic Tests in CancerIQ

Users can now place orders for any of Myriad’s tumor tests in the Testing Tab in CIQ, and produce a pre-filled Myriad Precise TRF by entering information into the Precise TRF Wizard.

DOWNLOAD

Ordering a Myriad Test in CancerIQ

To standardize the experience for ordering a test across our platform, we have removed the DocuSign function for Myriad tests. You will now be able to generate a Myriad Test Requisition Form and have the option to add an e-signature directly through CancerIQ!

DOWNLOAD
TRAINING VIDEOS

Workflow Sample Demos from the AHEAD Program

Generating a survey code in CIQ

 

Taking the CIQ Survey

 

Generating the intake form and Myriad TRF

 

CANCERIQ & MYRIAD

Shared Partnership Successes

Featured Case Studies of Key Customers Using Myriad & CancerIQ

Whether expanding specialist capacity or improving adherence to payer-supported screenings, leading health systems choose CancerIQ to identify at-risk patients earlier, streamline personalized care pathways and drive better clinical and financial outcomes. See how health systems are using CancerIQ.

ADVENTIST (SYSTEMWIDE)

AdventistHealth

Adventist Health used CancerIQ to expand specialist capacity and navigate high-risk patients across the health system, resulting in a $15 million increase in revenue over 5 years.  #healthsystem

ADVENTIST HEALTH ST. HELENA

AdventistHealth

Adventist Health St. Helena Women’s Center achieved a 25% increase in breast cancer screening compliance and a 290% increase in colon cancer screening compliance. Adventist White Memorial Cancer Center tripled annual genetic testing with CancerIQ — reaching over 150 patients per year, 75% of whom are from underserved patient populations.   #womenshealth

DIGNITY HEALTH

Dignity Cancer Logo

Dignity Health, part of CommonSpirit Health, saw a 10X increase in genetic testing after using CancerIQ to offer services at the point-of-care in obstetrics. Now the health system is expanding across more locations and specialties, including primary care and gastroenterology. #genetics

METHODIST JENNIE EDMUNSON


Within the first year of CancerIQ implementation, Jennie Edmundson’s early data suggests the technology could be driving a shift toward earlier detection of breast cancer at the NAPBC accredited center. #breastcenter

Featured Customer Webinar Series

Dignity Cancer Logo

Phoenix-based Dignity Health Cancer Institute, now part of the CommonSpirit Health network, wanted to expand access to cancer genetic testing and counseling with telegenetics, but was limited to the bandwidth of a single genetic counselor. Dignity Health turned to CancerIQ to automate administrative processes, create more capacity for high-risk patients, and demonstrate program value. In the first year with CancerIQ, Dignity Health saw a two-fold increase in patient volume, increased retention of high-risk patients and secured long-term funding for continued growth of the program.

ASHLEY NAVARRO, MS, CGC | Dignity Health Cancer Institute

Telegenetic Counselor, CGC

RACHEL MCCONACHIE, RN, BSN, MSN | Division Director, Oncology

Oncology Service Line Administrator

ABOUT CANCERIQ

Featured CancerIQ Product & Services Resources

SOLUTION 1-PAGER

For Health Systems

DOWNLOAD
SOLUTION 1-PAGER

For Oncology

DOWNLOAD
SOLUTION 1-PAGER

For Breast Centers

DOWNLOAD
SOLUTION 1-PAGER

For Women's Health

DOWNLOAD
WEBINAR SERIES

Quarterly Product Webinars

Q1 2025: Recording & Slides
Q4 2024: Recording & Slides

BRANDNG

Looking for brand assets?

Visit our Brand Page (with password Prevent123) or additional branding assets, including our logos.

WEBINAR SERIES

WATCH: Unlocking the VALUE of Genetics with Real Data and Real ROI

Speaker Headshots (4)-1speakerheadshots-brittany

We know that cancer genetic risk assessment (GCRA) and a risk-based approach to cancer prevention and early detection are essential for clinical success, and even payers acknowledge the financial benefits. So why isn’t it happening at scale in provider organizations? Many genetics and high-risk programs lack the financial resources or staffing to deliver these services broadly. To help you make a strong business case to leadership in 2025, we’re offering a on-demand webinar series that will highlight both the clinical and financial benefits of comprehensive GCRA programs.